Organigram Global opened lower at $0.85, compared with its previous close of $0.85. In the last trading session, the stock traded between $0.82 and $0.86. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Organigram Global is now worth
$ 9.45
Resulting in a loss of
$ 90.55 (90.55%)
Note: Past profits do not guarantee future returns.
Rating from 1 Analysts
Today's Change
$-0.02 (-2.19%)
Day High
$0.86
Day Low
$0.82
Day Open
$0.85
Prev Close
$0.85
Volume
5,61,012
1W Return
-13.02%
1M Return
-10.12%
3M Return
-31.84%
6M Return
-36.26%
1Y Return
-49.09%
Market Cap ($ Mn)
118
PE Ratio
2.79
PB Ratio
0.50
PEG Ratio
0.00
ROE
-7.05%
ROCE
-9.09%
EPS (TTM)
$0.75
1 Week
-13.02%
1 Month
-10.12%
3 Months
-31.84%
6 Months
-36.26%
9 Months
-36.26%
Organigram targets $8-10M annualized savings with global operating model
Organigram targets $8-10 million in annualized run-rate cost savings by Fiscal 2027. SG&A expenses expected to reduce by $4.5-5.5 million, driving over half of total savings. One-time integration costs estimated at $2 million in Fiscal 2027. Three brands discontinued and SKU assortment trimmed to simplify portfolio.
28 days agoOrganigram Global to host 2026 investor session on September 30
Organigram Global Inc. announced its 2026 OG Investor Session for September 30 at 4:00 pm ET. CEO James Yamanaka will present updates on global growth strategy and new leadership. The event includes presentations from CFO Greg Guyatt and President Finn Age Hänsel. Registration is open with a fireside Q&A session featuring investor-submitted questions.
2mo agoOrganigram fixes Sanity earnout at 85% of max value, expands global footprint
Organigram Global Inc. has accelerated the integration of Sanity Group GmbH by fixing the earnout at 85% of its maximum value, comprising €20 million in cash and €76 million in shares. New leadership appointments include Finn Age Hänsel as President, Rest of World & Chief Strategy Officer, and Adrian Frenzel as Global Chief Operating Officer. Sanity contributed over 35% of consolidated net revenue in the last quarter, driving the strategic unification of operations across Canada and Europe.
2mo agoOrganigram Global Inc. Q3 Results: Net revenue rises 49% YoY
Organigram Global Inc. delivered record Q3 FY26 results, with net revenue rising 49% YoY to $105.8 million and adjusted EBITDA jumping 136% to $13.4 million. The turnaround was fueled by the Sanity Group acquisition, which contributed €25 million in net revenue. Net income swung to $105.5 million from a prior-year loss, driven by fair value gains and operational improvements.
3mo agoOrganiGram Holdings Q3 sales $76.4M beat estimates
OrganiGram Holdings delivered strong Q3 results with sales of $76.413 million, significantly beating the $67.660 million analyst consensus. The figure represents a 49.41 percent year-over-year growth from $51.142 million, highlighting improved operational execution.
3mo agoOrganigram Global Raises FY26 Revenue Guidance Above Estimates
Organigram Global confirms FY2026 revenue will exceed $255.197 million, beating the $241.360 million estimate. The update reflects strong operational performance and positive market sentiment for the cannabis producer.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $1,437.29 | +0.35% | $13,52,123.38M | 39.43 | |
| $280.41 | -0.13% | $6,75,033.80M | 31.06 | |
| $294.98 | +0.37% | $5,21,411.37M | 72.17 | |
| $147.18 | -0.59% | $3,62,834.91M | 117.74 | |
| $160.32 | -1.80% | $3,26,222.34M | 23.23 | |
| $185.48 | -0.69% | $2,87,691.54M | 24.32 | |
| $468.11 | +0.62% | $2,53,205.85M | 26.86 | |
| $169.73 | -0.67% | $2,10,522.74M | - | |
| $29.45 | +0.31% | $1,67,860.70M | 36.79 | |
| $41.09 | +0.96% | $1,39,300.36M | 11.15 | |
| $62.91 | +0.18% | $1,28,593.45M | 14.67 | |
| $48.43 | +0.41% | $1,16,984.89M | 23.63 |
An investment of $100 made 5 years ago in Organigram Global is now worth
$ 9.45
Resulting in a loss of
$ 90.55 (90.55%)
Note: Past profits do not guarantee future returns.
